Prospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 4978-4985
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4978
Table 1 Patient characteristics
Characteristicn = 223
Age in yr62.3 ± 9.9
Sex, n
Male159
Female64
BMI in kg/m223.0 ± 3.4
Comorbidities, n
Diabetes mellitus15
Hypertension72
Preoperative serum albumin in g/L38.3 ± 3.2
Preoperative hemoglobin in g/L123.4 ± 24.9
Preoperative CRP in g/L6.6 ± 10.3
CA 19-9 in ng/mL
≥ 3743
< 37180
CEA in ng/mL
≥ 526
< 5197
Lymphocyte count as × 109/L
≥ 39
< 3214
CRP on POD 3 in mg/L99.7 ± 60.9
ALB on POD 1 in g/L32.7 ± 3.6
ASA ≥ 3, n122
Clinical stage I/II/III/IV, n67/44/103/9
Mode of surgical approach, n
Laparoscopic18
Open205
Type of resection, n
Distal gastrectomy82
Proximal gastrectomy24
Total gastrectomy117
Degree of lymph node dissection ≥ 2, n180
Operation time in min239.1 ± 66.9
Blood loss in mL228.6 ± 146.2
Postoperative complications as Clavien-Dindo grade, n
I and II40
≥ III22
Postoperative stay in d15.8 ± 8.6
Table 2 Univariate analysis of risk factors associated with postoperative complications
CharacteristicOR95%CIP value
Age ≥ 75 yr1.3300.476-3.7150.586
Sex0.6420.342-1.2020.166
BMI of < 18.5 kg/m20.2770.034-2.2320.228
Comorbidities
Diabetes mellitus3.2591.128-9.4140.029
Hypertension0.7280.382-1.3890.336
Preoperative serum albumin of < 35 g/L1.0481.018-1.1090.015
Preoperative hemoglobin of < 120 g/L1.4870.817-2.7050.194
Preoperative CRP of ≥ 10 g/L1.3360.512-3.4860.553
CA 19-9 of ≥ 37 ng/mL1.3280.647-2.7230.439
CEA of ≥ 5 ng/mL1.1770.483-2.8650.720
Lymphocyte count of ≥ 3 × 109/L0.3140.038-2.5600.279
CRP on POD 3 in mg/L4.6532.435-8.889< 0.001
△ALB of ≥ 14.0%16.8376.403-44.275< 0.001
ASA of ≥ 31.0070.559-1.8150.981
Clinical stage of ≥ II1.7981.255-2.6860.009
Mode of surgical approach1.2060.588-2.4750.610
Type of resection1.2911.006-1.8960.013
Degree of lymph node dissection ≥ 22.2630.948-5.3990.066
Operation time of ≥ 250 min1.6210.896-2.9310.110
Blood loss of ≥ 200 mL1.4170.758-2.6510.275
Table 3 Multivariate analysis of risk factors associated with postoperative complications
CharacteristicOR95%CIP value
Age ≥ 75 yr1.0530.248-4.4700.945
Sex0.5720.237-1.3800.214
BMI of < 18.5 kg/m20.1470.013-1.6660.122
Comorbidities
Diabetes mellitus1.2340.322-4.7260.759
Hypertension0.9890.397-2.4630.981
Preoperative serum albumin of < 35 g/L0.9140.897-1.0670.093
Preoperative hemoglobin of < 120 g/L1.8040.748-4.3530.189
Preoperative CRP of ≥ 10 g/L1.0080.210-4.8400.993
CA 19-9 of ≥ 37 ng/mL1.1970.431-3.3270.730
CEA of ≥ 5 ng/mL0.7940.233-2.7060.713
Lymphocyte count of ≥ 3 × 109/L0.1920.018-2.0480.172
CRP on POD 3 in mg/L4.2961.887-9.7800.001
△ALB of ≥ 14.0%17.9576.073-53.095< 0.001
ASA of ≥ 30.9290.406-2.1270.861
Clinical stage of ≥ II1.1980.355-2.2860.109
Mode of surgical approach1.7370.576-5.2350.327
Type of resection0.7910.506-1.8960.063
Degree of lymph node dissection ≥ 23.4851.163-10.4460.026
Operation time of ≥ 250 min1.4480.624-3.3550.389
Blood loss of ≥ 200 mL1.4180.636-3.1600.393
Table 4 Univariate analysis of postoperative complications associated with median value of ∆ALB
CharacteristicAll, n = 223∆ALB < 14.0%, n = 101∆ALB ≥ 14.0%, n = 122P value
Overall1362 (27.8)5 (5.0)57 (46.7)< 0.001
Mild complications1340 (17.9)3 (3.0)37 (30.3)< 0.001
Major complications1322 (9.9)2 (2.0)20 (16.4)< 0.001
Postoperative stay in d215.8 ± 8.614.1 ± 4.217.2 ± 10.80.007
CCI all patients40 (0-20.9)0 (0-0)8.7 (0-26.2)< 0.001